Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (25)
Jaap N.E. Bakers, Adriaan D. de Jongh, Tommy M. Bunte, Lindsay Kendall, Steve S. Han, Noam Epstein, Arseniy Lavrov, Anita Beelen, Johanna M.A. Visser-Meily, Leonard H. van den Berg & Ruben P. A. van Eijk. (2022) Using the ALSFRS-R in multicentre clinical trials for amyotrophic lateral sclerosis: potential limitations in current standard operating procedures. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 500-507.
Read now
Read now
Umberto Manera, Luca Solero, Christina Nicole Fournier, Antonio Canosa, Rosario Vasta, Alessandro Bombaci, Maurizio Grassano, Francesca Palumbo, Maria Claudia Torrieri, Paolina Salamone, Federico Casale, Giuseppe Fuda, Cristina Moglia, Andrea Calvo & Adriano Chiò. (2022) Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 424-429.
Read now
Read now
Helia Mojtabavi, Shahriar Nafissi, Behrooz Mahmoodi-Bakhtiari, Davood Fathi & Farzad Fatehi. (2021) Persian adaptation of Edinburgh Cognitive and Behavioural Screen (ECAS). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 426-433.
Read now
Read now
Umberto Manera, Sara Cabras, Margherita Daviddi, Rosario Vasta, Maria Claudia Torrieri, Francesca Palumbo, Alessandro Bombaci, Maurizio Grassano, Luca Solero, Laura Peotta, Barbara Iazzolino, Antonio Canosa, Andrea Calvo, Adriano Chiò & Cristina Moglia. (2021) Validation of the Italian version of self-administered ALSFRS-R scale. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 151-153.
Read now
Read now
Madison Gilmore, Lauren Elman, Suma Babu, Patricia Andres & Mary Kay Floeter. (2020) Measuring disease progression in primary lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:sup1, pages 59-66.
Read now
Read now
. (2020) ALSUntangled 56: “ten red flags”-things to be wary of in alternative or off-label products. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 642-647.
Read now
Read now
Susana Pinto, Marta Gromicho & Mamede de Carvalho. (2019) Assessing upper limb function with ALSFRS-R in amyotrophic lateral sclerosis patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:5-6, pages 445-448.
Read now
Read now
Isaäc Bos, Klaske Wynia, Gea Drost, Josué Almansa & Jan B. M. Kuks. (2018) The extremity function index (EFI), a disability severity measure for neuromuscular diseases: psychometric evaluation. Disability and Rehabilitation 40:13, pages 1561-1568.
Read now
Read now
Iyas Daghlas, Teresa E. Lever & Emily Leary. (2018) A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 206-211.
Read now
Read now
H Blasco, F Patin, CR Andres, P Corcia & PH Gordon. (2016) Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection. Expert Opinion on Pharmacotherapy 17:12, pages 1669-1682.
Read now
Read now
Lisa A. van der Kleij, Ashley R. Jones, I Nick Steen, Carolyn A. Young, Pamela J. Shaw, Christopher E. Shaw, P. Nigel Leigh, Martin R. Turner & Ammar Al-Chalabi. (2015) Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:7-8, pages 442-447.
Read now
Read now
Martin McElhiney, Judith G. Rabkin, Raymond Goetz, Jonathan Katz, Robert G. Miller, Dallas A. Forshew, William David, Merit Cudkowicz, Jonathan D. Glass, Stanley Appel, Ericka Simpson & Hiroshi Mitsumoto. (2014) Seeking a measure of clinically meaningful change in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 398-405.
Read now
Read now
Matthew Gladman, Celina Dharamshi & Lorne Zinman. (2014) Economic burden of amyotrophic lateral sclerosis: A Canadian study of out-of-pocket expenses. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 426-432.
Read now
Read now
Hiroshi Mitsumoto, Pam Factor-Litvak, Howard Andrews, Raymond R. Goetz, Leslie Andrews, Judith G. Rabkin, Martin McElhiney, Jeri Nieves, Regina M. Santella, Jennifer Murphy, Jonathan Hupf, Jess Singleton, David Merle, Mary Kilty, Daragh Heitzman, Richard S. Bedlack, Robert G. Miller, Jonathan S. Katz, Dallas Forshew, Richard J. Barohn, Eric J. Sorenson, Bjorn Oskarsson, J. Americo M. Fernandes Filho, Edward J. Kasarskis, Catherine Lomen-Hoerth, Tahseen Mozaffar, Yvonne D. Rollins, Sharon P. Nations, Andrea J. Swenson, Jeremy M. Shefner, Jinsy A. Andrews & Boguslawa A. Koczon-Jaremko. (2014) ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): Study methodology, recruitment, and baseline demographic and disease characteristics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:3-4, pages 192-203.
Read now
Read now
Vânia Almeida, Mamede de Carvalho, Manuel Scotto, Susana Pinto, Anabela Pinto, Benjamim Ohana & Michael Swash. (2013) Primary lateral sclerosis: Predicting functional outcome. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:2, pages 141-145.
Read now
Read now
Patricia Lillo, Sharon Savage, Eneida Mioshi, Matthew C. Kiernan & John R. Hodges. (2012) Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum. Amyotrophic Lateral Sclerosis 13:1, pages 102-109.
Read now
Read now
Patricia Lillo, Eneida Mioshi, Margaret C. Zoing, Matthew C. Kiernan & John R. Hodges. (2011) How common are behavioural changes in amyotrophic lateral sclerosis?. Amyotrophic Lateral Sclerosis 12:1, pages 45-51.
Read now
Read now
Shafqat Inam, Steve Vucic, Nina E. Brodaty, Margie C. Zoing & Matthew C. Kiernan. (2010) The 10-metre gait speed as a functional biomarker in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 11:6, pages 558-561.
Read now
Read now
Carmen Castrillo-Viguera, Daniela L. Grasso, Elizabeth Simpson, Jeremy Shefner & Merit E. Cudkowicz. (2010) Clinical significance in the change of decline in ALSFRS-R. Amyotrophic Lateral Sclerosis 11:1-2, pages 178-180.
Read now
Read now
Lorne Zinman, Reza Sadeghi, Marek Gawel, Dan Patton & Alex Kiss. (2008) Are statin medications safe in patients with ALS?. Amyotrophic Lateral Sclerosis 9:4, pages 223-228.
Read now
Read now
Hua Wang, Kylyana S. Larriviere, Kristen E. Keller, Kathleen A. Ware, Ted M. Burns, Mark A. Conaway, David Lacomis, Gary L. Pattee, Lawrence H. Phillips$suffix/text()$suffix/text(), Nina J. Solenski, Sasa A. Zivkovic & James P. Bennett$suffix/text()$suffix/text(). (2008) R(+) pramipexole as a mitochondrially focused neuroprotectant: Initial early phase studies in ALS. Amyotrophic Lateral Sclerosis 9:1, pages 50-58.
Read now
Read now
J. Iłżecka. (2008) Decreased serum endoglin level in patients with amyotrophic lateral sclerosis: a preliminary report. Scandinavian Journal of Clinical and Laboratory Investigation 68:4, pages 348-351.
Read now
Read now
Petra Kaufmann, Gilbero Levy, Jacquelina Montes, Richaro Buchsbaum, Alexandra I. Barsdorf, Vanessa Battista, Rachel Arbing, Paul H. Gordon, Hiroshi Mitsumoto, Brvce Levin, John L. P. Thompson, Petra Kaufmann, Gilbero Levy, Jacquelina Montes, Richaro Buchsbaum, Alexandra I. Barsdorf, Vanessa Battista, Rachel Arbing, Paul H. Gordon, Hiroshi Mitsumoto, Brvce Levin & John L. P. Thompson. (2007) Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial. Amyotrophic Lateral Sclerosis 8:1, pages 42-46.
Read now
Read now
J. Iłżecka. (2007) Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis. Scandinavian Journal of Clinical and Laboratory Investigation 67:3, pages 264-269.
Read now
Read now
M. Muddasir Qureshi, Douglas Hayden, Leo Urbinelli, Kimberly Ferrante, Kristyn Newhall, Daniela Myers, Sarah Hilgenberg, Ryan Smart, Robert H. Brown & Merit E. Cudkowicz. (2006) Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis 7:3, pages 173-182.
Read now
Read now
Articles from other publishers (64)
Fabiola De Marchi, Katia Mareschi, Ivana Ferrero, Roberto Cantello, Franca Fagioli & Letizia Mazzini. (2023) Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis. Cytotherapy 25:8, pages 798-802.
Crossref
Crossref
Fabiola De Marchi, Massimo Saraceno, Maria Francesca Sarnelli, Eleonora Virgilio, Roberto Cantello & Letizia Mazzini. (2023) Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment. Neurological Sciences 44:8, pages 2795-2802.
Crossref
Crossref
Hiroshi Mitsumoto, Ken Cheung, Björn Oskarsson, Howard F. Andrews, Grace E. Jang, Jinsy A. Andrews, Jaimin S. Shah, Joseph Americo Fernandes, Martin McElhiney & Regina M. Santella. (2023) Randomized double-blind personalized N-of-1 clinical trial to test the safety and potential efficacy of TJ-68 for treating muscle cramps in amyotrophic lateral sclerosis (ALS): study protocol for a TJ-68 trial. Trials 24:1.
Crossref
Crossref
Cara Donohue, Giselle Carnaby, Mary Catherine Reilly, Ryan J. Colquhoun, David Lacomis & Kendrea L. (Focht) Garand. (2023) A meta-analysis of post-exercise outcomes in people with amyotrophic lateral sclerosis. eNeurologicalSci 31, pages 100452.
Crossref
Crossref
Andrew Hannaford, Karen Byth, Nathan Pavey, Robert D. Henderson, Susan Mathers, Merrilee Needham, David Schultz, Parvathi Menon, Matthew C. Kiernan & Steve Vucic. (2022) Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosis. Muscle & Nerve 67:1, pages 17-24.
Crossref
Crossref
André Maier, Matthias Boentert, Peter Reilich, Simon Witzel, Susanne Petri, Julian Großkreutz, Moritz Metelmann, Paul Lingor, Isabell Cordts, Johannes Dorst, Daniel Zeller, René Günther, Tim Hagenacker, Torsten Grehl, Susanne Spittel, Joachim Schuster, Albert Ludolph & Thomas Meyer. (2022) ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale. Neurological Research and Practice 4:1.
Crossref
Crossref
Laura J. Ball, Jenenne A. Geske, Elizabeth Burton & Gary L. Pattee. (2022)
A clinical bulbar assessment scale (
CBAS
) for amyotrophic lateral sclerosis
. Muscle & Nerve 66:6, pages 694-701.
Crossref
Crossref
Nora Hertel, Magdalena Kuzma-Kozakiewicz, Marta Gromicho, Julian Grosskreutz, Mamede de Carvalho, Hilmi Uysal, Reinhard Dengler, Susanne Petri & Sonja Körner. (2022) Analysis of routine blood parameters in patients with amyotrophic lateral sclerosis and evaluation of a possible correlation with disease progression—a multicenter study. Frontiers in Neurology 13.
Crossref
Crossref
Fabiola De Marchi, Marcella Serioli, Alessandro Collo, Evelyn Gisell Belotti, Francesca Alloatti, Giampaolo Biroli, Andrea Bolioli, Roberto Cantello, Sergio Riso & Letizia Mazzini. (2022) A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients. Journal of Clinical Medicine 11:15, pages 4286.
Crossref
Crossref
Cara Donohue, Lauren Tabor Gray, Jennifer Chapin, Amber Anderson, Lauren DiBiase, James P. Wymer & Emily K. Plowman. (2021) Discriminant ability of the 3‐ounce water swallow test to detect aspiration in amyotrophic lateral sclerosis. Neurogastroenterology & Motility 34:7.
Crossref
Crossref
Filipe Gonçalves & Bruno Magalhães. (2021) Effects of prolonged interruption of rehabilitation routines in amyotrophic lateral sclerosis patients. Palliative and Supportive Care 20:3, pages 369-374.
Crossref
Crossref
Çağatay Berke Erdaş, Emre Sümer & Seda Kibaroğlu. (2022) CNN-based severity prediction of neurodegenerative diseases using gait data. DIGITAL HEALTH 8, pages 205520762210751.
Crossref
Crossref
Can Sun, Christina N. Fournier, Shan Ye, Nan Zhang, Yan Ma & Dongsheng Fan. (2021) Chinese validation of the Rasch‐Built Overall Amyotrophic Lateral Sclerosis Disability Scale. European Journal of Neurology 28:6, pages 1876-1883.
Crossref
Crossref
Stanisław Maksymowicz, Paula Kukołowicz, Tomasz Siwek & Agnieszka Rakowska. (2020) Validation of the revised Amyotrophic Lateral Sclerosis Functional Rating Scale in Poland and its reliability in conditions of the medical experiment. Neurological Sciences 42:3, pages 943-949.
Crossref
Crossref
Alessandro de Sire, Marco Invernizzi, Martina Ferrillo, Francesca Gimigliano, Alessio Baricich, Carlo Cisari, Fabiola De Marchi, Pier Luigi Foglio Bonda, Letizia Mazzini & Mario Migliario. (2021) Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study. NeuroRehabilitation 48:1, pages 49-57.
Crossref
Crossref
Fabiola De Marchi, Alessandro Stecco, Zeno Falaschi, Francesco Filippone, Alessio Pasché, Alen Bebeti, Massimiliano Leigheb, Roberto Cantello & Letizia Mazzini. (2020) Detection of White Matter Ultrastructural Changes for Amyotrophic Lateral Sclerosis Characterization: A Diagnostic Study from Dti-Derived Data. Brain Sciences 10:12, pages 996.
Crossref
Crossref
Monika Barczewska, Stanisław Maksymowicz, Izabela Zdolińska-Malinowska, Tomasz Siwek & Mariusz Grudniak. (2020) Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis: an Original Study. Stem Cell Reviews and Reports 16:5, pages 922-932.
Crossref
Crossref
Bartłomiej Baumert, Anna Sobuś, Monika Gołąb-Janowska, Edyta Paczkowska, Karolina Łuczkowska, Dorota Rogińska, Alicja Zawiślak, Sławomir Milczarek, Bogumiła Osękowska, Wioletta Pawlukowska, Agnieszka Meller, Karolina Machowska-Sempruch, Agnieszka Wełnicka, Krzysztof Safranow, Przemysław Nowacki & Bogusław Machaliński. (2020) Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells—Focus on Immunological Pathways in Patients with ALS. Cells 9:8, pages 1822.
Crossref
Crossref
Fabiola De Marchi, James D. Berry, James Chan, Sarah Caldwell, Amy Ellrodt, Jennifer Scalia, Katherine Burke, Ton Fang, Rachel Clark Sisodia, Lee H. Schwamm, Lidia M. V. R. Moura & Sabrina Paganoni. (2020) Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis. Journal of Neurology 267:6, pages 1754-1759.
Crossref
Crossref
Umberto Manera, Andrea Calvo, Margherita Daviddi, Antonio Canosa, Rosario Vasta, Maria Claudia Torrieri, Maurizio Grassano, Maura Brunetti, Sandra D'Alfonso, Lucia Corrado, Fabiola De Marchi, Cristina Moglia, Fabrizio D'Ovidio, Gabriele Mora, Letizia Mazzini & Adriano Chiò. (2020) Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based study. Journal of Neurology, Neurosurgery & Psychiatry 91:3, pages 291-297.
Crossref
Crossref
Hiroshi Mitsumoto, Codruta Chiuzan, Madison Gilmore, Yuan Zhang, Zachary Simmons, Sabrina Paganoni, Yasushi Y. Kisanuki, Lorne Zinman, Omar Jawdat, Eric Sorenson, Mary Kay Floeter, Erik P. Pioro, J. Americo M. Fernandes Filho, Daragh Heitzman, Christina Nicole Fournier, Bjorn Oskarsson, Terry Heiman‐Patterson, Nicholas Maragakis, Nanette Joyce, Ghazala Hayat, Sharon Nations, Stephen Scelsa, David Walk, Lauren Elman, Jonathan Hupf & Brittany McHale. (2019) Primary lateral sclerosis (PLS) functional rating scale: PLS‐specific clinimetric scale. Muscle & Nerve 61:2, pages 163-172.
Crossref
Crossref
Özden O. Dalgıç, F. Safa Erenay, Kalyan S. Pasupathy, Osman Y. Özaltın, Brian A. Crum & Mustafa Y. Sir. (2019) Tollgate-based progression pathways of ALS patients. Journal of Neurology 266:3, pages 755-765.
Crossref
Crossref
Yana Yunusova, Emily K. Plowman, Jordan R. Green, Carolina Barnett & Peter Bede. (2019) Clinical Measures of Bulbar Dysfunction in ALS. Frontiers in Neurology 10.
Crossref
Crossref
. (2018) Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. European Journal of Human Genetics 26:10, pages 1537-1546.
Crossref
Crossref
Shunya Nakane, Koji Fujita, Shingo Azuma, Ryo Urushihara, Masaki Kamada, Masafumi Harada, Yuishin Izumi & Ryuji Kaji. (2018) CSF cystatin C and diffusion tensor imaging parameters as biomarkers of upper motor neuron degeneration in amyotrophic lateral sclerosis. Clinical Neurology and Neurosurgery 172, pages 162-168.
Crossref
Crossref
Kevin B. Boylan, Mark A. Ross & Eric J. Sorenson. 2017. Neurodegeneration. Neurodegeneration
137
160
.
Jun Yan, Yun Xu, Li Zhang, Hui Zhao, Ling Jin, Wei-Guo Liu, Lei-Hua Weng, Zuo-Han Li & Ling Chen. (2016) Increased Expressions of Plasma Galectin-3 in Patients with Amyotrophic Lateral Sclerosis. Chinese Medical Journal 129:23, pages 2797-2803.
Crossref
Crossref
Tracy L. Peters, John D. Beard, David M. Umbach, Kelli Allen, Jean Keller, Daniela Mariosa, Dale P. Sandler, Silke Schmidt, Fang Fang, Weimin Ye & Freya Kamel. (2016) Blood levels of trace metals and amyotrophic lateral sclerosis. NeuroToxicology 54, pages 119-126.
Crossref
Crossref
Shahriar Nafissi, Hadi Kazemi, Taki Tiraihi, Nahid Beladi-Moghadam, Soghrat Faghihzadeh, Elham Faghihzadeh, Davoud Yadegarynia, Mostafa Sadeghi, Leili Chamani-Tabriz, Abdollah Khanfakhraei & Taher Taheri. (2016) Intraspinal delivery of bone marrow stromal cell-derived neural stem cells in patients with amyotrophic lateral sclerosis: A safety and feasibility study. Journal of the Neurological Sciences 362, pages 174-181.
Crossref
Crossref
Kee Hong ParkRock Bum KimJiwon YangJung-Hwan OhSu-Yeon ParkDong-Gun KimJe-Young ShinJung-Joon Sung. (2016) Reference Range of Respiratory Muscle Strength and Its Clinical Application in Amyotrophic Lateral Sclerosis: A Single-Center Study. Journal of Clinical Neurology 12:3, pages 361.
Crossref
Crossref
Seong-il OhKi-Wook OhHee-Jin KimJin-Seok ParkSeung Hyun Kim. (2016) Impaired Perception of Emotional Expression in Amyotrophic Lateral Sclerosis. Journal of Clinical Neurology 12:3, pages 295.
Crossref
Crossref
L. Jensen, L. H. Jørgensen, R. D. Bech, U. Frandsen & H. D. Schrøder. (2016) Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis. BioMed Research International 2016, pages 1-12.
Crossref
Crossref
A. E. Elia, S. Lalli, M. R. Monsurrò, A. Sagnelli, A. C. Taiello, B. Reggiori, V. La Bella, G. Tedeschi & A. Albanese. (2015) Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. European Journal of Neurology 23:1, pages 45-52.
Crossref
Crossref
Huub Creemers, Hepke Grupstra, Frans Nollet, Leonard H. van den Berg & Anita Beelen. (2014) Prognostic factors for the course of functional status of patients with ALS: a systematic review. Journal of Neurology 262:6, pages 1407-1423.
Crossref
Crossref
Seward B. Rutkove. (2015) Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis. Neurotherapeutics 12:2, pages 384-393.
Crossref
Crossref
Seong-il OhSoojeong BaekJin-Seok ParkLiying PiaoKi-Wook OhSeung Hyun Kim. (2015) Prognostic Role of Serum Levels of Uric Acid in Amyotrophic Lateral Sclerosis. Journal of Clinical Neurology 11:4, pages 376.
Crossref
Crossref
Foteini Christidi, Ioannis Zalonis, Stavroula Kyriazi, Michalis Rentzos, Efstratios Karavasilis, Elisabeth A. Wilde & Ioannis Evdokimidis. (2013) Uncinate fasciculus microstructure and verbal episodic memory in amyotrophic lateral sclerosis: a diffusion tensor imaging and neuropsychological study. Brain Imaging and Behavior 8:4, pages 497-505.
Crossref
Crossref
Seong-il Oh, Aram Park, Hee-Jin Kim, Ki-Wook Oh, Hojin Choi, Min-Jung Kwon, Chang-Seok Ki, Hee-Tae Kim & Seung Hyun Kim. (2014) Spectrum of Cognitive Impairment in Korean ALS Patients without Known Genetic Mutations. PLoS ONE 9:2, pages e87163.
Crossref
Crossref
Seong-il OhHee-Jin KimAram ParkKi-Wook OhHyun Seung GwakSeung Hyun Kim. (2014) Clinical Features and Prognostic Effects of Behavioral and Psychological Symptoms in Patients with Amyotrophic Lateral Sclerosis. Dementia and Neurocognitive Disorders 13:1, pages 1.
Crossref
Crossref
Franco Franchignoni, Gabriele Mora, Andrea Giordano, Paolo Volanti & Adriano Chiò. (2013) Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis. Journal of Neurology, Neurosurgery & Psychiatry 84:12, pages 1340-1345.
Crossref
Crossref
Daniel M Pastula, Dan H Moore & Richard S Bedlack. (2012) Creatine for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Craig M. McDonald & William M. FowlerJr.Jr.. (2012) The Role of the Neuromuscular Medicine and Physiatry Specialists in the Multidisciplinary Management of Neuromuscular Disease. Physical Medicine and Rehabilitation Clinics of North America 23:3, pages 475-493.
Crossref
Crossref
Joanna Iłżecka. (2011) Serum caspase-9 levels are increased in patients with amyotrophic lateral sclerosis. Neurological Sciences 33:4, pages 825-829.
Crossref
Crossref
Patricia L. Andres, Linda M. Skerry, Theodore L. Munsat, Brenda J. Thornell, Jackie Szymonifka, David A. Schoenfeld & Merit E. Cudkowicz. (2011) Validation of a new strength measurement device for amyotrophic lateral sclerosis clinical trials. Muscle & Nerve 45:1, pages 81-85.
Crossref
Crossref
J. Iłżecka. (2011) EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis. Acta Neurologica Scandinavica 124:6, pages 424-428.
Crossref
Crossref
F.J. Rodríguez de Rivera, C. Oreja Guevara, I. Sanz Gallego, B. San José Valiente, A. Santiago Recuerda, M.A. Gómez Mendieta, J. Arpa & E. Díez Tejedor. (2011) Outcome of patients with amyotrophic lateral sclerosis attending in a multidisciplinary care unit. Neurología (English Edition) 26:8, pages 455-460.
Crossref
Crossref
F.J. Rodríguez de Rivera, C. Oreja Guevara, I. Sanz Gallego, B. San José Valiente, A. Santiago Recuerda, M.A. Gómez Mendieta, J. Arpa & E. Díez Tejedor. (2011) Evolución de pacientes con esclerosis lateral amiotrófica atendidos en una unidad multidisciplinar. Neurología 26:8, pages 455-460.
Crossref
Crossref
Joanna Iłżecka. (2011) Granzymes A and B levels in serum of patients with amyotrophic lateral sclerosis. Clinical Biochemistry 44:8-9, pages 650-653.
Crossref
Crossref
Daniel M. Pastula, Dan H Moore & Richard S Bedlack. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
D. Keizman, M. Ish-Shalom, S. Berliner, N. Maimon, Y. Vered, I. Artamonov, J. Tsehori, B. Nefussy & V.E. Drory. (2009) Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress?. Journal of the Neurological Sciences 285:1-2, pages 95-99.
Crossref
Crossref
J. Iłżecka. (2009) Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis. Acta Neurologica Scandinavica 120:2, pages 119-122.
Crossref
Crossref
P. Wicks, M. P. Massagli, C. Wolf & J. Heywood. (2009) Measuring function in advanced ALS: validation of ALSFRS-EX extension items. European Journal of Neurology 16:3, pages 353-359.
Crossref
Crossref
Clifton L. Gooch, Seth L. Pullman, Dikoma C. Shungu, Aziz M. Uluğ, Stephen Chan, Paul H. Gordon, Ming-X. Tang, Xiangling Mao, Lewis P. Rowland & Hiroshi Mitsumoto. 2009. Motor Unit Number Estimation (MUNE) and Quantitative EMG - Selected Presentations from the Second International Symposium on MUNE and QEMG, Snowbird, Utah, USA, 18–20 August 2006. Motor Unit Number Estimation (MUNE) and Quantitative EMG - Selected Presentations from the Second International Symposium on MUNE and QEMG, Snowbird, Utah, USA, 18–20 August 2006
153
162
.
J. Iłżecka. (2008) Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis. Acta Neurologica Scandinavica 117:5, pages 343-346.
Crossref
Crossref
Aleksandar Radunović, Hiroshi Mitsumoto & P Nigel Leigh. (2007) Clinical care of patients with amyotrophic lateral sclerosis. The Lancet Neurology 6:10, pages 913-925.
Crossref
Crossref
H. MitsumotoA. M. UluğS. L. PullmanC. L. GoochS. ChanM. -X. TangX. MaoA. P. HaysA. G. FloydV. BattistaJ. MontesS. HayesS. DashnawP. KaufmannP. H. GordonJ. HirschB. LevinL. P. RowlandD. C. Shungu. (2007) Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 68:17, pages 1402-1410.
Crossref
Crossref
Adam Czaplinski, Albert A. Yen, Ericka P. Simpson & Stanley H. Appel. (2006) Predictability of disease progression in amyotrophic lateral sclerosis. Muscle & Nerve 34:6, pages 702-708.
Crossref
Crossref
Allitia B. DiBernardo & Merit E. Cudkowicz. (2006) Translating preclinical insights into effective human trials in ALS. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1762:11-12, pages 1139-1149.
Crossref
Crossref
J. MontesG. LevyS. AlbertP. KaufmannR. BuchsbaumP. H. GordonH. Mitsumoto. (2006) Development and evaluation of a self-administered version of the ALSFRS-R. Neurology 67:7, pages 1294-1296.
Crossref
Crossref
J. Iłżecka. (2006) Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis. Acta Neurologica Scandinavica 114:3, pages 205-209.
Crossref
Crossref
Ashok Verma & Julie Steele. (2006) Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis. Muscle & Nerve 34:2, pages 235-237.
Crossref
Crossref
C. Benaïm, C. Desnuelle & M. Fournier-Méhouas. (2006) Échelles fonctionnelles et évaluation des fonctions motrices dans la Sclérose Latérale Amyotrophique. Revue Neurologique 162, pages 131-137.
Crossref
Crossref
Jennica MC Winhammar, Dominic B Rowe, Robert D Henderson & Matthew C Kiernan. (2005) Assessment of disease progression in motor neuron disease. The Lancet Neurology 4:4, pages 229-238.
Crossref
Crossref
Edmar Zanoteli. (1999) Severity and functional ability scale for amyotrophic lateral sclerosis patients: preliminar results. Revista Neurociências 16:3, pages 174.
Crossref
Crossref